Sugi Predict

Sugi Predict / Compounds / SCHEMBL5348192

SCHEMBL5348192

SCHEMBL5348192

CCCC(SC(C)C)n1c(C)nc2c(Oc3ccccc3)nc3c(c21)CCCC3

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.33
▸ BCHE P06276 10/20 0.33
▸ ACHE P22303 10/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5355565 0.83 POLB (0.33) ADORA3BCHEACHEL3MBTL1POLB
SCHEMBL5406203 0.79 HSD17B10 (0.32) ADORA3BCHEACHEL3MBTL1POLB
SCHEMBL6477156 0.77 HTT (0.33) BCHEPOLBSMN1; SMN2LMNAHTT
SCHEMBL6486089 0.75 BCHE (0.33) BCHEACHEL3MBTL1POLBLMNA
SCHEMBL5348190 0.74 NPC1 (0.32) BCHEACHENPC1RAB9ALMNA
SCHEMBL6483879 0.73 ACHE (0.33) BCHEACHEL3MBTL1POLBNPC1
SCHEMBL5368947 0.70 BCHE (0.36) BCHEACHELMNAALDH1A1HTT
SCHEMBL5355562 0.69 BCHE (0.32) BCHEACHEPOLBLMNAHTT
SCHEMBL5406199 0.66 BCHE (0.32) BCHEACHEPOLBLMNAALDH1A1
SCHEMBL24287266 0.64 LMNA (0.57) ADORA3BCHEACHELMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276515-B2 Thioether substituted imidazoquinolines COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-10-02 — — US disclosed
US-6949649-B2 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES CO. (US) 2005-09-27 — — US disclosed
US-20050209268-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2005-09-22 — — US disclosed
EP-1451191-A1 THIOETHER SUBSTITUTED IMIDAZOQUINOLINES 3M Innovative Properties Company (US) 2004-09-01 — — EP disclosed
US-20040097736-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-05-20 — — US disclosed
US-6667312-B2 Useful as immune response modifiers 3M INNOVATIVE PROPERTIES COMPANY 2003-12-23 — — US disclosed
WO-2003050121-A1 THIOETHER SUBSTITUTED IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 — — WO disclosed
US-20030100764-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2003-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209268-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 ADORA3 4199/4885BCHE 4028/4885ACHE 4781/4885
US-20040097736-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 ADORA3 4199/4885BCHE 4028/4885ACHE 4781/4885
US-20030100764-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 ADORA3 4199/4885BCHE 4028/4885ACHE 4781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.